To investigate the role of GCN5 in pressure overload-induced cardiac hypertrophy in vivo, GCN5 was overexpressed in mice using the AAV9 system containing null and GCN5 via tail vein injection. This evidence concerns the gene KAT2B and cardiac hypertrophy.